Invion Limited IVX.AX Stock
Invion Limited Price Chart
Invion Limited IVX.AX Financial and Trading Overview
| Invion Limited stock price | 0.0050 AUD |
| Previous Close | 0.006 AUD |
| Open | 0.006 AUD |
| Bid | 0.006 AUD x 0 |
| Ask | 0.007 AUD x 0 |
| Day's Range | 0.006 - 0.006 AUD |
| 52 Week Range | 0.006 - 0.02 AUD |
| Volume | 380K AUD |
| Avg. Volume | 796.07K AUD |
| Market Cap | 38.53M AUD |
| Beta (5Y Monthly) | 1.239463 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.11 AUD |
IVX.AX Valuation Measures
| Enterprise Value | 30.49M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.782054 |
| Price/Book (mrq) | 2 |
| Enterprise Value/Revenue | 7.74 |
| Enterprise Value/EBITDA | -21.134 |
Trading Information
Invion Limited Stock Price History
| Beta (5Y Monthly) | 1.239463 |
| 52-Week Change | -25.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.02 AUD |
| 52 Week Low | 0.006 AUD |
| 50-Day Moving Average | 0.00685 AUD |
| 200-Day Moving Average | 0.008895 AUD |
IVX.AX Share Statistics
| Avg. Volume (3 month) | 796.07K AUD |
| Avg. Daily Volume (10-Days) | 539.91K AUD |
| Shares Outstanding | 6.42B |
| Float | 3.62B |
| Short Ratio | N/A |
| % Held by Insiders | 47.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -51.42% |
| Operating Margin (ttm) | -51.44% |
| Gross Margin | 26.74% |
| EBITDA Margin | -36.62% |
Management Effectiveness
| Return on Assets (ttm) | -6.29% |
| Return on Equity (ttm) | -10.34% |
Income Statement
| Revenue (ttm) | 3.94M AUD |
| Revenue Per Share (ttm) | 0.001 AUD |
| Quarterly Revenue Growth (yoy) | 49.79% |
| Gross Profit (ttm) | 969.12K AUD |
| EBITDA | -1442561 AUD |
| Net Income Avi to Common (ttm) | -2025575 AUD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.03M AUD |
| Total Cash Per Share (mrq) | 0.001 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 13.207 |
| Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -421989 AUD |
| Levered Free Cash Flow (ttm) | -4691680 AUD |
Profile of Invion Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 100 Albert Road |
| ZIP | 3205 |
| Phone | 61 3 9692 7222 |
| Website | https://www.inviongroup.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
Q&A For Invion Limited Stock
What is a current IVX.AX stock price?
Invion Limited IVX.AX stock price today per share is 0.0050 AUD.
How to purchase Invion Limited stock?
You can buy IVX.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Invion Limited?
The stock symbol or ticker of Invion Limited is IVX.AX.
Which industry does the Invion Limited company belong to?
The Invion Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Invion Limited have in circulation?
The max supply of Invion Limited shares is 6.42B.
What is Invion Limited Price to Earnings Ratio (PE Ratio)?
Invion Limited PE Ratio is now.
What was Invion Limited earnings per share over the trailing 12 months (TTM)?
Invion Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Invion Limited company belong to?
The Invion Limited sector is Healthcare.